No items found.
No items found.
No items found.
Left chevron

Go Back

Anatomy & Physiology

Platelet Aggregation in Thrombosis: Clinical Essentials

Explore platelet aggregation in thrombosis and hemostasis with Dr. Busti: essential physiology for clinical practice.

Video thumbnail

To view this video, please enable marketing cookies from Cookie Preferences in the footer.

Horizontal dot pattern

Platelet aggregation is a core step in hemostasis—and when it’s dysregulated, it drives thrombosis. In this lecture from This is Why, Dr. Busti will break down platelet physiology in a clear, clinically relevant way so you can understand how platelets form a primary hemostatic plug, how a thrombus develops, and why this process matters in real patient care.

You’ll learn how to:

- How platelet adhesion starts (the role of von Willebrand factor (vWF) and GPIb)

- How platelet activation amplifies the response (ADP and thromboxane A2 / TXA2)

- How platelet aggregation occurs (GPIIb/IIIa binding fibrinogen)

- The key endogenous “brakes” that limit clot growth (nitric oxide and prostacyclin / PGI2)

- How clinicians think about platelet function testing and antiplatelet drugs in practice

The goal = make medical education easy and clinically relevant.

Chapter Table of Contents
00:00 Platelet activation and aggregation: why it matters clinically
01:37 Platelets 101: role in arterial vs venous thrombosis
02:24 Normal platelet count range and what “abnormal” means
03:40 Thrombocytopenia: bleeding risk thresholds you must know
04:09 Major causes of low platelets (ITP, TTP/HUS, HIT, DIC)
05:02 Why platelets drop: destruction vs decreased production vs sequestration
06:54 Hemostasis overview: clot initiation, plug formation, breakdown
07:22 Endothelial injury: collagen + vWF trigger platelet activation
09:21 Clinical outcomes: MI, ischemic stroke, DVT complications
09:50 White vs red thrombus: composition drives therapy
11:25 Antiplatelets vs anticoagulants: why drug choice differs by clot type
14:03 Key platelet activators and drug targets (P2Y12, TxA2, GPIIb/IIIa)
18:30 Natural antiplatelet forces: nitric oxide and prostacyclin (PGI2)
19:50 Platelet function testing and real-world monitoring options

If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#PlateletAggregation #Thrombosis #Hemostasis #PlateletPhysiology #drbusti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This is why - membership

More than just access—it’s where understanding deepens.

Create a free account or log in to gain access to this content!

Dot pattern graphic

Dive Deeper

Bonus Video (ad free)

Deep Dive video thumbnail

To view this video, please enable marketing cookies.

Downloads

Platelet Aggregation in Thrombosis: Clinical Essentials

Dive Deeper

Bonus Video

Downloads

Platelet Aggregation in Thrombosis: Clinical Essentials